Radosa, J.C.;                     Kasoha, M.;                     Doerk, M.;                     Cullmann, A.;                     Kaya, A.C.;                     Linxweiler, M.;                     Radosa, M.P.;                     Takacs, Z.;                     Tirincsi, A.;                     Lang, S.;     
    et al.    The 3q Oncogene SEC62 Predicts Response to Neoadjuvant Chemotherapy and Regulates Tumor Cell Migration in Triple Negative Breast Cancer. Int. J. Mol. Sci. 2023, 24, 9576.
    https://doi.org/10.3390/ijms24119576
    AMA Style
    
                                Radosa JC,                                 Kasoha M,                                 Doerk M,                                 Cullmann A,                                 Kaya AC,                                 Linxweiler M,                                 Radosa MP,                                 Takacs Z,                                 Tirincsi A,                                 Lang S,         
        et al.        The 3q Oncogene SEC62 Predicts Response to Neoadjuvant Chemotherapy and Regulates Tumor Cell Migration in Triple Negative Breast Cancer. International Journal of Molecular Sciences. 2023; 24(11):9576.
        https://doi.org/10.3390/ijms24119576
    
    Chicago/Turabian Style
    
                                Radosa, Julia C.,                                 Mariz Kasoha,                                 Merle Doerk,                                 Annika Cullmann,                                 Askin C. Kaya,                                 Maximilian Linxweiler,                                 Marc P. Radosa,                                 Zoltan Takacs,                                 Andrea Tirincsi,                                 Sven Lang,         
         and et al.        2023. "The 3q Oncogene SEC62 Predicts Response to Neoadjuvant Chemotherapy and Regulates Tumor Cell Migration in Triple Negative Breast Cancer" International Journal of Molecular Sciences 24, no. 11: 9576.
        https://doi.org/10.3390/ijms24119576
    
    APA Style
    
                                Radosa, J. C.,                                 Kasoha, M.,                                 Doerk, M.,                                 Cullmann, A.,                                 Kaya, A. C.,                                 Linxweiler, M.,                                 Radosa, M. P.,                                 Takacs, Z.,                                 Tirincsi, A.,                                 Lang, S.,                                 Jung, M.,                                 Puppe, J.,                                 Linxweiler, B.,                                 Wagner, M.,                                 Bohle, R. M.,                                 Solomayer, E.-F.,                                 & Zimmermann, J. S. M.        
        
        (2023). The 3q Oncogene SEC62 Predicts Response to Neoadjuvant Chemotherapy and Regulates Tumor Cell Migration in Triple Negative Breast Cancer. International Journal of Molecular Sciences, 24(11), 9576.
        https://doi.org/10.3390/ijms24119576